C4 Therapeutics, Inc.: cashflow_financing
| Value | {"amount": 462000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:05.352034+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6c89e244-adf7-4225-b4ca-70b3c67dbd69
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-033865Retrieved: 2026-08-19T17:06:05.352034+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/cashflow-financing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6c89e244-adf7-4225-b4ca-70b3c67dbd69
History
- no predecessors — first report